About the Company
We do not have any company description for Vor Biopharma Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Vor Biopharma Inc.
Vor Biopharma Inc.'s (NASDAQ:VOR) top holders are insiders and they are ...
A look at the shareholders of Vor Biopharma Inc. (NASDAQ:VOR) can tell us which group is most powerful. The group holding the most number of shares in the company, around 32% to be precise, is ...
What is Wedbush’s Forecast for Vor Biopharma Q1 Earnings?
Vor Biopharma Inc. (NYSE:VOR – Free Report) – Equities research analysts at Wedbush issued their Q1 2026 earnings estimates for Vor Biopharma in a research report issued on Thursday, May 8th.
Vor Biopharma Inc. (VOR)'s Technical Outlook is Bright After ... - Nasdaq
Vor Biopharma Inc. (VOR) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, VOR's 50-day simple moving average crossed above ...
Positive Outlook for Vor Biopharma’s Trem-cel in AML Trials Leads to ...
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological ...
Vor Biopharma (VOR) Receives a Buy from Barclays
Vor Biopharma has an analyst consensus of Strong Buy, with a price target consensus of $16.10, representing a 1,839.29% upside. In a report released on August 9, JonesTrading also reiterated a Buy ...
Vor Biopharma Inc. Advanced Charts | VOR | Barron's
Vor Biopharma Inc. advanced stock charts by Barron's. View VOR historical stock data and compare to other stocks, and exchanges.
What's Going On With Vor Biopharma Shares Friday?
As part of the PIPE, Vor will issue a total of 55,871,260 shares of common stock and accompanying warrants to purchase an additional 69,839,075 shares, priced at $0.99425 per share and warrants.
H.C. Wainwright Upgrades Vor Biopharma (VOR) to a Buy, Sets a $3 Price ...
Vor Biopharma Inc. (NASDAQ:VOR) is one of the hot penny stocks to invest in now. In a report released on June 30, Swayampakula Ramakanth from H.C. Wainwright upgraded Vor Biopharma Inc.
Vor Biopharma (VOR) Jumps 10% on Addition of 2 CEOs to Board
Early last week, Vor Biopharma Inc. (NASDAQ:VOR) announced the addition of Alexander Cumbo and Michel Detheux to its board of directors, sparking confidence among investors amid ongoing efforts to ...
Vor Biopharma Inc. (NYSE:VOR) Receives $11.36 Average Price Target from ...
Vor Biopharma has a fifty-two week low of $0.63 and a fifty-two week high of $2.43. The firm has a market cap of $60.44 million, a price-to-earnings ratio of -0.53 and a beta of -0.45.
Similar Companies
Loading the latest forecasts...